FENTANYL CITRATE

Generic: FENTANYL CITRATE

Fresenius Kabi USAManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
FENTANYL CITRATEActive Substance
2020-09-01Original Approval

FENTANYL CITRATE is FDA application ANDA212086, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DEPENDENCE
3,935 reports
2
OVERDOSE
2,456 reports
3
DEATH
2,065 reports
4
DRUG ABUSE
1,737 reports
5
TOXICITY TO VARIOUS AGENTS
1,385 reports
6
ILL-DEFINED DISORDER
1,288 reports
7
CARDIAC ARREST
918 reports
8
RESPIRATORY ARREST
737 reports
9
DRUG INEFFECTIVE
715 reports
10
DRUG HYPERSENSITIVITY
628 reports